Kjaer, Christian – Trademark Portfolio

Entity Type: 01

Kjaer, Christian holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ELLEVET. The owner is based in 1260 Copenhagen K.

Bredgade 47, 4th

1260 Copenhagen K 1260 , DK

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ELLEVET
ELLEVET
Registered 2019
ELLEVET
ELLEVET
Abandoned 2018

Trademark Classifications

Kjaer, Christian's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Kjaer, Christian have?

Kjaer, Christian has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Kjaer, Christian file in?

Kjaer, Christian files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Kjaer, Christian's most well-known trademarks?

Kjaer, Christian's registered trademark portfolio includes well-known marks such as ELLEVET. These are among 1 currently registered trademark in the portfolio.

What is Kjaer, Christian's trademark registration success rate?

Kjaer, Christian has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.